FDA Says Abbott Recalls Amplatzer Steerable Delivery Sheath For Increased Risk Of Air Embolism; FDA Says Identifies Abbott's Recall Of Amplatzer Steerable Delivery Sheath As A Class I Recall
Portfolio Pulse from Benzinga Newsdesk
The FDA has announced that Abbott (ABT) is recalling its Amplatzer Steerable Delivery Sheath due to an increased risk of air embolism. The FDA has classified this as a Class I recall, the most serious type of recall which indicates that use of these devices may cause serious injuries or death.
July 26, 2023 | 2:47 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Abbott's recall of its Amplatzer Steerable Delivery Sheath, classified as a Class I recall by the FDA, could potentially harm the company's reputation and financial performance.
The recall of a product, especially a Class I recall, can have significant negative impacts on a company. It can lead to financial losses due to the costs associated with the recall, potential lawsuits, and a decrease in sales due to a damaged reputation. Therefore, this news is likely to have a negative impact on Abbott's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100